
Eisai has criticised NICE for being too narrow minded on assessing new drugs, and has warned it may pull its …

Eisai is expanding its UK headquarters to support the company’s growing European, Middle Eastern and African business. The expansion will …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations

